Increased intestinal delivery of viable Saccharomyces boulardii by encapsulation in microspheres

Pharmaceutical Research
Sandrine GraffChristine Charrueau

Abstract

Although probiotics are of a major potential therapeutic interest, their efficacy is usually limited by poor bioavailability of viable microorganisms on site. The aim of this study was to protect the probiotic Saccharomyces boulardii from degradation in order to ensure a greater number of viable yeast in the colon. Alginate microspheres coated with or not with chitosan were used to encapsulate the yeast by an extrusion method. The efficiency of encapsulation was assessed both in vitro and in vivo. In vitro, less than 1% of the non-encapsulated probiotic survived after 120 min at pH 1.1, whereas the majority of encapsulated yeast cells remained entrapped within both types of microspheres. Further exposure to a pH 6.8 allowed the release of about 35% of viable yeasts. In vivo, the percentage of viable yeast excreted over 96 h after a single oral dose of 2 x 10(8) cfu/100 g in rats was 2.5% for nonencapsulated yeast and reached 13.3 and 9.0% of the dose administered for the uncoated and chitosan-coated microspheres, respectively. Given the dose-dependent efficacy of S. boulardii and the efficiency of microencapsulation in protecting the yeast from degradation, alginate microspheres could be of great interest in therapeutic applica...Continue Reading

References

Jul 1, 1989·Biopharmaceutics & Drug Disposition·H BlehautR H Levy
May 1, 1993·Journal of Pediatric Gastroenterology and Nutrition·J P ButsM Delmee
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M L Lorenzo-LamosaM J Alonso
Mar 25, 1999·International Journal of Pharmaceutics·C TuleuJ C Chaumeil
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·G W ElmerR N Greenberg
Aug 29, 2000·Digestive Diseases and Sciences·M GuslandiP A Testoni
Sep 26, 2000·Journal of Dairy Science·K AdhikariL Fernando
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M SurawiczG W Elmer
Feb 13, 2001·International Journal of Pharmaceutics·J H CuiB J Lee
May 14, 2003·Digestive Diseases and Sciences·Philippe GirardJean-Marie Gillardin
Jul 4, 2003·European Journal of Gastroenterology & Hepatology·Mario GuslandiPier Alberto Testoni
Jul 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf LamprechtYoshiaki Kawashima
Aug 2, 2003·Drug Development and Industrial Pharmacy·Anil K AnalWillem F Stevens
Aug 14, 2003·International Journal of Food Microbiology·Wen-Chian LianCheng-Chun Chou
Oct 7, 2004·Canadian Journal of Microbiology·Juliana L R FiettoIeso M Castro
Nov 26, 2004·Journal of Agricultural and Food Chemistry·J S LeeH J Park
Jan 25, 2005·International Journal of Pharmaceutics·Anil K Anal, Willem F Stevens
Mar 18, 2005·Biotechnology and Bioengineering·Farid TalebniaMohammad J Taherzadeh
Aug 9, 2005·Gastroenterology Clinics of North America·Jean-Paul Buts, Paul Bernasconi
Oct 22, 2005·Digestive Diseases and Sciences·Philippe GirardJean-Marie Gillardin
Jul 11, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Meera George, T Emilia Abraham

❮ Previous
Next ❯

Citations

Apr 30, 2013·International Journal of Pharmaceutics·Cong LiuLongxiao Liu
Feb 16, 2012·Critical Reviews in Food Science and Nutrition·Thomas HeidebachUlrich Kulozik
Jun 16, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael T CookVitaliy V Khutoryanskiy
Jun 10, 2015·Critical Reviews in Food Science and Nutrition·Jun ChenJoshua Gong
Mar 25, 2014·International Journal of Pharmaceutics·Michael T CookVitaliy V Khutoryanskiy
Apr 1, 2017·Critical Reviews in Food Science and Nutrition·Philippe E RamosAntónio A Vicente
May 14, 2020·Critical Reviews in Food Science and Nutrition·Georgia FrakolakiConstantina Tzia
Sep 15, 2018·Probiotics and Antimicrobial Proteins·Sultan Arslan-TontulAhmet Gorgulu
Feb 19, 2010·Journal of Microencapsulation·Géraldine HébrardMuriel Subirade
Jan 11, 2013·Biomacromolecules·Michael T CookVitaliy V Khutoryanskiy
Aug 29, 2021·Polymers·Roxana GheorghitaMihai Covasa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.